Generation and characterisation of an equine macrophage cell line (e-CAS cells) derived from equine bone marrow cells

Veterinary Immunology and Immunopathology

Volumn 97, Issue 1-2, 2004, Pages 65-76

  Werners, Arno H ^a   Bull, Sarah ^a   Fink Gremmels, Johanna ^a   Bryant, Clare E ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell line; Characterisation; Equine; In vitro; Inflammation; Macrophage

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ESTERASE; NITROGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; GIEMSA STAIN; HORSE; KINETICS; MACROPHAGE; MORPHOLOGY; NONHUMAN; SIGNAL TRANSDUCTION;

EQUIDAE; ESCHERICHIA COLI;

EID: 0346786295     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2003.08.012     Document Type: Article

References (57)

1. Amit M., Itskovitz-Eldor J. Derivation and spontaneous differentiation of human embryonic stem cells. J. Anat. 200:2002;225-232.
2. Appleton I., Tomlinson A., Willoughby D.A. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 35:1996;27-78.
3. Azuma Y., Ohura K. Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kappaB DNA binding in THP-1 differentiated to macrophage-like cells. Scand. J. Immunol. 56:2002;260-269.
4. Barton M.H., Moore J.N. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. Circ Shock. 44:1994;216-220.
5. Barton M.H., Collatos C., Moore J.N. Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet. J. 28:1996;382-389.
6. Barton M.H., Moore J.N., Norton N. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. Am. J. Vet. Res. 58:1997;1300-1307.
7. Benton H.P., MacDonald M.H., Tesch A.M. Effects of adenosine on bacterial lipopolysaccharide- and interleukin 1-induced nitric oxide release from equine articular chondrocytes. Am. J. Vet. Res. 63:2002;204-210.
8. Bertoni G., Kuhnert P., Peterhans E., Pauli U. Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK(15). J. Immunol. Meth. 160:1993;267-271.
9. Blasi E., Mathieson B.J., Varesio L., Cleveland J.L., Borchert P.A., Rapp U.R. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature. 318:1985;667-670.
10. Bohbot A., Faradji A., Schmitt M., Oberling F., Uttwiller F., Ruch J.V., Braun S., Hartmann D., Bartholeyns J., Poindron P. Establishment and characterisation of somatic hybrids between human differentiated macrophages and mouse myeloma NS1 cells. Int. J. Cell Cloning. 8:1990;63-79.
11. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97:1968;77-89.
12. Bueno A.C., Seahorn T.L., Cornick-Seahorn J., Horohov D.W., Moore R.M. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Am. J. Vet. Res. 60:1999;676-696.
13. Dahm A.M., de B.A., Linat A., von T.C., Wyder M., Suter M.M. Cultivation and characterisation of primary and subcultured equine keratinocytes. Equine Vet. J. 34:2002;114-120.
14. Daniel S.L., Legendre A.M., Moore R.N., Rouse B.T. Isolation and functional studies on feline bone marrow derived macrophages. Vet. Immunol. Immunopathol. 36:1993;107-122.
15. Davis W.C., Hamilton M.J. Comparison of the unique characteristics of the immune system in different species of mammals. Vet. Immunol. Immunopathol. 63:1998;7-13.
16. Dinarello C.A. Proinflammatory cytokines. Chest. 118:2000;503-508.
17. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. NY Acad. Sci. 966:2002;290-303.
18. Fink-Gremmels J., van Miert A.S. Veterinary drugs: disposition, biotransformation and risk evaluation. Analyst. 119:1994;2521-2528.
19. Forman H.J., Torres M. Redox signaling in macrophages. Mol. Aspects Med. 22:2001;189-216.
20. Francey T., Schalch L., Brcic M., Peterhans E., Jungi T.W. Generation and functional characterization of ovine bone marrow-derived macrophages. Vet. Immunol. Immunopathol. 32:1992;281-301.
21. Frean S.P., Bryant C.E., Froling I.L., Elliott J., Lees P. Nitric oxide production by equine articular cells in vitro. Equine Vet. J. 29:1997;98-102.
22. 15N] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
23. Hammond R.A., Hannon R., Frean S.P., Armstrong S.J., Flower R.J., Bryant C.E. Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. Am. J. Vet. Res. 60:1999;426-431.
24. Hammond R.A., Flower R.J., Bryant C.E. Complete coding sequence of equine inducible nitric oxide synthase. Res. Vet. Sci. 72:2002;245.
25. Hawkins D.L., MacKay R.J., MacKay S.L., Moldawer L.L. Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages. Vet. Immunol. Immunopathol. 66:1998;1-10.
26. Henry M.M., Moore J.N. Clinical relevance of monocyte procoagulant activity in horses with colic. J. Am. Vet. Med. Assoc. 198:1991;843-848.
27. Hume D.A., Allan W., Golder J., Stephens R.W., Doe W.F., Warren H.S. Preparation and characterisation of human bone marrow-derived macrophages. J. Leukoc. Biol. 38:1985;541-552.
28. Jarvis G.E., Evans R.J. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. Res. Vet. Sci. 57:1994;317-324.
29. Jesch N.K., Dorger M., Enders G., Rieder G., Vogelmeier C., Messmer K., Krombach F. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparisson. Environ. Health Perspect. 105(suppl. 5):1997;1297-1300.
30. Jungi T.W., Adler H., Adler B., Thony M., Krampe M., Peterhans E. Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation. Vet. Immunol. Immunopathol. 54:1996;323-330.
31. Kim S., Johnson V., Sharma R. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide. 7:2002;67.
32. Kretzschmar C., Kruger M. Examination of systemic tumor necrosis factor activity under physiologic and pathophysiologic conditions. Berl. Munch. Tierarztl. Wochenschr. 112:1999;91-97.
33. Lin C., Holland R.E. Jr., Williams N.M., Chambers T.M. Cultures of equine respiratory epithelial cells and organ explants as tools for the study of equine influenza virus infection. Arch. Virol. 146:2001;2239-2247.
34. Lowry O., Rosenbourgh N., Farr A., Randall R. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
35. Lutz M.B., Granucci F., Winzler C., Marconi G., Paglia P., Foti M., Assmann C.U., Cairns L., Rescigno M., Ricciardi-Castagnoli P. Retroviral immortalization of phagocytic and dendritic cell clones as a tool to investigate functional heterogeneity. J. Immunol. Meth. 174:1994;269-279.
36. Milam S.B., Mackay R.J., Skelley L.A. Secretion of tumor necrosis factor by endotoxin-treated equine mammary exudate macrophages: effect of dexamethasone and pentoxifylline. Cornell Vet. 82:1992;435-446.
37. Moore B.D., Balasuriya U.B., Hedges J.F., MacLachlan N.J. Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horses. Virology. 298:2002;39-44.
38. Neumann N.F., Barreda D., Belosevic M. Production of a macrophage growth factor(s) by a goldfish macrophage cell line and macrophages derived from goldfish kidney leukocytes. Dev. Comp. Immunol. 22:1998;417-432.
39. O'Hare M.J., Bond J., Clarke C., Takeuchi Y., Atherton A.J., Berry C., Moody J., Silver A.R., Davies D.C., Alsop A.E., Neville A.M., Jat P.S. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc. Natl. Acad. Sci. USA. 98:2001;646-651.
40. Olivier M., Berthon P., Chastang J., Cordier G., Lantier F. Establishment and characterisation of ovine blood monocyte-derived cell lines. Vet. Immunol. Immunopathol. 82:2001;139-151.
41. Olson N.C., Hellyer P.W., Dodam J.R. Mediators and vascular effects in response to endotoxin. Br. Vet. J. 151:1995;489-522.
42. Pauli U., Bertoni G., Duerr M., Peterhans E. A bioassay for the detection of tumor necrosis factor from eight different species: evaluation of neutralization rates of a monoclonal antibody against human TNF-alpha. J. Immunol. Meth. 171:1994;263-265.
43. Pirami L., Stockinger B., Corradin S.B., Sironi M., Sassano M., Valsasnini P., Righi M., Ricciardi-Castagnoli P. Mouse macrophage clones immortalized by retroviruses are functionally heterogeneous. Proc. Natl. Acad. Sci. USA. 88:1991;7543-7547.
44. Rathjen P.D., Lake J., Whyatt L.M., Bettess M.D., Rathjen J. Properties and uses of embryonic stem cells: prospects for application to human biology and gene therapy. Reprod. Fert. Dev. 10:1998;31-47.
45. Rodgerson D.H., Belknap J.K., Moore J.N., Fontaine G.L. Investigation of mRNA expression of tumor necrosis factor-alpha, interleukin-1beta, and cyclooxygenase-2 in cultured equine digital artery smooth muscle cells after exposure to endotoxin. Am. J. Vet. Res. 62:2001;1957-1963.
46. Schwarzbaum S., Halpern R., Diamond B. The generation of macrophage-like cell lines by transfection with SV40 origin defective DNA. J. Immunol. 132:1984;1158-1162.
47. Simmons E.J., Bertone A.L., Hardy J., Weisbrode S.E. Nitric oxide synthase activity in healthy and interleukin 1beta-exposed equine synovial membrane. Am. J. Vet. Res. 60:1999;714-716.
48. Sklar M.D., Tereba A., Chen B.D., Walker W.S. Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1. J. Cell. Physiol. 125:1985;403-412.
49. Song G.Y., Chung C.S., Jarrar D., Cioffi W.G., Ayala A. Mechanism of immune dysfunction in sepsis: inducible nitric oxide-meditated alterations in p38 MAPK activation. J. Trauma. 53:2002;276-283.
50. Tipold A., Zurbriggen A., Moore P., Schijns V., Jungi T.W. Generation and functional characterisation of canine bone marrow-derived macrophages. Res. Vet. Sci. 64:1998;125-132.
51. 2R123). J. Immunol. Meth. 186:1995;275-284.
52. van Furth R. Current view of the mononuclear phagocyte system. Hamatol. Bluttransfus. 27:1981;3-10.
53. Van Miert A.S. Present concepts on the inflammatory modulators with special reference to cytokines. Vet. Res. Commun. 26:2002;111-126.
54. Vetrovsky P., Kleschykov A.L., Entlicher G., Poindron P., Stoclet J.C. Nitric oxide generation from extracellularly applied NG-hydroxy-L-arginine in LPS activated RAW264 macrophages. Biochim. Biophys. Acta. 1334:1997;51-56.
55. Wan C.P., Park C.S., Lau B.H. A rapid and simple microfluorometric phagocytosis assay. J. Immunol. Meth. 162:1993;1-7.
56. Yam L.T., Li C.Y., Wolfe H.J., Moy P.W. Histochemical study of acute leukemia. Arch. Pathol. 97:1974;129-135.
57. Zipori D., Friedman A., Tamir M., Silverberg D., Malik Z. Cultured mouse marrow cell lines: interactions between fibroblastoid cells and monocytes. J. Cell Physiol. 118:1984;143-152.